CVS Group (LON:CVSG) Earns Hold Rating from Jefferies Financial Group

CVS Group (LON:CVSG)‘s stock had its “hold” rating restated by stock analysts at Jefferies Financial Group in a research report issued to clients and investors on Friday, Digital Look reports. They presently have a GBX 1,400 price target on the stock. Jefferies Financial Group’s target price suggests a potential upside of 11.66% from the stock’s previous close.

A number of other brokerages have also recently issued reports on CVSG. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 1,700 target price on shares of CVS Group in a report on Monday, July 27th. Berenberg Bank restated a “buy” rating and set a GBX 2,000 price target on shares of CVS Group in a research note on Thursday. Finally, Shore Capital Group restated a “hold” rating and set a GBX 1,400 price objective on shares of CVS Group in a report on Thursday. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of GBX 1,666.67.

CVS Group Stock Up 2.7%

CVSG stock opened at GBX 1,253.77 on Friday. The stock’s 50 day simple moving average is GBX 1,288.61 and its 200 day simple moving average is GBX 1,229.58. CVS Group has a fifty-two week low of GBX 1,062 and a fifty-two week high of GBX 1,648. The company has a debt-to-equity ratio of 92.34, a quick ratio of 0.90 and a current ratio of 1.07. The company has a market cap of £852.19 million, a P/E ratio of 18.20, a price-to-earnings-growth ratio of 1.77 and a beta of 1.07.

CVS Group (LON:CVSG) last announced its quarterly earnings data on Thursday, September 24th. The company reported GBX 85.60 EPS for the quarter. CVS Group had a return on equity of 5.35% and a net margin of 2.31%. On average, research analysts expect that CVS Group will post 93.9393939 earnings per share for the current fiscal year.

Insider Transactions at CVS Group

In related news, insider David Wilton bought 1,500 shares of the business’s stock in a transaction that occurred on Tuesday, August 4th. The shares were bought at an average price of GBX 1,276 per share, with a total value of £19,140. Also, insider Joanne Shaw purchased 1,592 shares of the firm’s stock in a transaction that occurred on Monday, August 10th. The shares were bought at an average price of GBX 1,287 per share, with a total value of £20,489.04. Insiders purchased a total of 3,860 shares of company stock valued at $4,956,696 over the last ninety days. 1.48% of the stock is currently owned by insiders.

Key CVS Group News

Here are the key news stories impacting CVS Group this week:

• Positive Sentiment: Dividend maintained: CVS Group recommended a final dividend for fiscal 2026, payable on December 4, 2026. The proposed payout supports shareholder returns and signals confidence in the company’s financial position. CVS Group recommends final dividend
• Positive Sentiment: Insider buying: Non-executive director Laura Hagan purchased 4,128 CVS Group shares, a modest positive signal that may indicate management confidence in the company’s longer-term prospects. CVS Group director share purchase
• Neutral Sentiment: Mixed analyst view: Berenberg reaffirmed its “buy” rating with a GBX 2,000 target, while Shore Capital maintained a “hold” rating with a GBX 1,400 target. The wide gap highlights differing views on CVS Group’s growth and valuation prospects.
• Negative Sentiment: Annual results drew a negative market reaction: CVS Group reported quarterly EPS of GBX 85.60, a net margin of 2.31% and return on equity of 5.35%. Although the company remains profitable, these figures suggest limited margins, which may have disappointed investors after the full-year results. CVS Group full-year earnings results

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.